Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis
Authors
Keywords
Statins, Parkinson disease, Cohort studies, Meta-analysis, Observational studies, Case-control studies, North America, Publication ethics
Journal
PLoS One
Volume 11, Issue 3, Pages e0152564
Publisher
Public Library of Science (PLoS)
Online
2016-03-29
DOI
10.1371/journal.pone.0152564
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study
- (2015) Xuemei Huang et al. MOVEMENT DISORDERS
- Influence of simvastatin on dopaminergic neurons of lipopolysaccharide–induced rat model of Parkinson's disease
- (2015) Tan Wang et al. Asian Pacific Journal of Tropical Medicine
- Statins in neurological disorders: An overview and update
- (2014) Anna Maria Malfitano et al. PHARMACOLOGICAL RESEARCH
- Discontinuation of statin therapy associates with Parkinson disease: A population-based study
- (2013) Y.-C. Lee et al. NEUROLOGY
- Prospective Study of Statin Use and Risk of Parkinson Disease
- (2012) Xiang Gao ARCHIVES OF NEUROLOGY
- Simvastatin Inhibited the Apoptosis of PC12 Cells Induced by 1-Methyl-4-Phenylpyridinium Ion via Inhibiting Reactive Oxygen Species Production
- (2012) Xudong Xu et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Simvastatin Induces Neuroprotection in 6-OHDA-Lesioned PC12 via the PI3K/AKT/Caspase 3 Pathway and Anti-Inflammatory Responses
- (2012) Yun-Qi Xu et al. CNS Neuroscience & Therapeutics
- Statin use and risk of Parkinson’s disease: a meta-analysis of observational studies
- (2012) Krishna Undela et al. JOURNAL OF NEUROLOGY
- Simvastatin Prevents Dopaminergic Neurodegeneration in Experimental Parkinsonian Models: The Association with Anti-Inflammatory Responses
- (2011) Junqiang Yan et al. PLoS One
- Statins — increasing or reducing the risk of Parkinson's disease?
- (2010) Amalia M. Dolga et al. EXPERIMENTAL NEUROLOGY
- Statin use and Parkinson's disease in Denmark
- (2010) Beate Ritz et al. MOVEMENT DISORDERS
- Lovastatin ameliorates α-synuclein accumulation and oxidation in transgenic mouse models of α-synucleinopathies
- (2009) Andrew O. Koob et al. EXPERIMENTAL NEUROLOGY
- Statins: Mechanisms of neuroprotection
- (2009) Peter J. van der Most et al. PROGRESS IN NEUROBIOLOGY
- Use of Statins and the Risk of Parkinson???s Disease
- (2008) Claudia Becker et al. DRUG SAFETY
- Statin use and the risk of Parkinson disease: a nested case control study
- (2008) Ali Samii et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia Aging Study
- (2008) Xuemei Huang et al. MOVEMENT DISORDERS
- Statin use and the risk of Parkinson disease
- (2008) A. D. Wahner et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started